R&D service classification

scientific reagent

It mainly includes: catalysts, ligands and active small molecular compounds.

Accelerate the reaction process of compounds, improve the reaction yield of catalyst products and active small molecule compounds. R&D personnel use such products to generate seed compounds and lead compounds, and then screen and optimize lead compounds with research value through a large number of activity tests, and finally determine clinical candidates.

Active small molecule compounds include: inhibitors, agonists and natural products, etc.

Catalysts and ligands: noble metal homogeneous catalysts, phosphine ligands and cheap metal catalysts.

new medical research

The company is engaged in the research and development of biomedicine, and mainly serves new drug research and development institutions including CRO institutions and scientific research institutes. It is applied to the discovery of new drug targets, the screening and optimization of hit compounds, the screening and optimization of lead compounds, and the determination of clinical candidates, etc. A key link in the development of new drugs.

Drug molecular building blocks are mainly used in the key links of new drug research and development, such as drug target discovery, screening and optimization of hit compounds, screening and optimization of lead compounds, and determination of clinical candidates, which can greatly save research and development time and improve research and development efficiency. The company continues to increase the production of drug molecular building blocks with excellent technical level and good market prospects, and continues to extend to the clinical research and commercial production stages of new drug research and development, so as to more comprehensively and fully assist new drug research and development, and improve the efficiency of new drug research and development .

Antibody research

Committed to the research and development of biological agents such as genes, recombinant proteins, antibodies, and phage libraries, with independent research and development as the core, and around professional and technical personnel, it has successively built protein expression and purification platforms, antibody customization platforms, antibody engineering platforms, antibody drug platforms, and quality Analysis platform and model animal genetic engineering research platform. Based on the one-chain solution for antibody drug development, we mainly provide customers with recombinant protein expression and production, antibody preparation, phage library construction and screening, monoclonal antibody drug development (antibody screening, antibody sequencing, antibody analysis, antibody humanization and Affinity maturation, epitope mapping, antibody engineering and antibody pharmacodynamics), stable cell line construction and cGMP production, cellular immunity (CAR-T/CAR-NK), protein crystallography, proteomics, bioinformatics, Technical services such as pharmacology and toxicology.